Hypermarcas Revenue 2009-2019 | HYPMY

Hypermarcas annual/quarterly revenue history and growth rate from 2009 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Hypermarcas revenue for the quarter ending March 31, 2019 was $0.102B, a 64.4% decline year-over-year.
  • Hypermarcas revenue for the twelve months ending March 31, 2019 was $0.835B, a 26.14% decline year-over-year.
  • Hypermarcas annual revenue for 2018 was $1.019B, a 10.58% decline from 2017.
  • Hypermarcas annual revenue for 2017 was $1.14B, a 20.86% increase from 2016.
  • Hypermarcas annual revenue for 2016 was $0.943B, a 4.45% increase from 2015.
Hypermarcas Annual Revenue
(Millions of US $)
2018 $1,019
2017 $1,140
2016 $943
2015 $903
2014 $2,000
2013 $1,985
2012 $1,994
2011 $1,998
2010 $1,804
2009 $1,029
2008 $743
Hypermarcas Quarterly Revenue
(Millions of US $)
Q1 2019 $102
Q4 2018 $236
Q3 2018 $241
Q2 2018 $256
Q1 2018 $286
Q4 2017 $277
Q3 2017 $302
Q2 2017 $266
Q1 2017 $295
Q4 2016 $250
Q3 2016 $250
Q2 2016 $230
Q1 2016 $213
Q4 2015 $-300
Q3 2015 $376
Q2 2015 $409
Q1 2015 $418
Q4 2014 $512
Q3 2014 $476
Q2 2014 $509
Q1 2014 $476
Q4 2013 $498
Q3 2013 $505
Q2 2013 $468
Q1 2013 $480
Q4 2012 $529
Q3 2012 $491
Q2 2012 $475
Q1 2012 $466
Q4 2011 $343
Q3 2011 $560
Q2 2011 $587
Q1 2011 $508
Q4 2010 $557
Q3 2010 $472
Q2 2010 $422
Q1 2010 $361
Q4 2009 $390
Q3 2009 $267
Q2 2009 $205
Q1 2009 $167
Q4 2008
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $5.064B $0.978B
Hypera S.A. is a pharmaceutical company. It engages in development of pharmaceuticals, dermocosmetics, vitamin supplements, and health products. Hypera serves customers primarily in Latin America. The company was formerly known as Hypermarcas S.A. and is headquartered in Sao Paulo, Brazil.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $59.346B 36.55
Astellas Pharma (ALPMY) Japan $27.779B 13.24
Takeda Pharmaceutical (TAK) Japan $27.107B 8.46
Eisai (ESALY) Japan $14.406B 24.77
Merck (MKGAF) Germany $14.152B 19.31
Grifols, S.A (GRFS) Spain $14.136B 18.03
UCB SA (UCBJF) Belgium $13.914B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.383B 20.06
Neurocrine Biosciences (NBIX) United States $9.295B 0.00
Ionis Pharmaceuticals (IONS) United States $8.843B 19.07
IPSEN SA ADR (IPSEY) France $8.581B 0.00
Sage Therapeutics (SAGE) United States $8.451B 0.00
Catalent (CTLT) United States $7.395B 29.27
Jazz Pharmaceuticals (JAZZ) Ireland $7.318B 9.63
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 19.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.058B 0.00
STADA ARZNEIMI (STDAF) Germany $5.547B 0.00
Orion OYJ (ORINY) Finland $5.275B 27.16
United Therapeutics (UTHR) United States $3.768B 0.00
Nektar Therapeutics (NKTR) United States $3.544B 0.00
FibroGen (FGEN) United States $3.446B 86.20
Evotec AG (EVTCY) Germany $3.399B 46.53
Taro Pharmaceutical Industries (TARO) Israel $3.093B 11.09
Tilray (TLRY) Canada $2.925B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.758B 63.24
PTC Therapeutics (PTCT) United States $2.304B 0.00
Portola Pharmaceuticals (PTLA) United States $2.065B 0.00
Xencor (XNCR) United States $2.009B 43.80
Zogenix (ZGNX) United States $1.830B 0.00
Heron Therapeutics (HRTX) United States $1.611B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.577B 0.00
Corcept Therapeutics (CORT) United States $1.562B 21.47
USANA Health Sciences (USNA) United States $1.544B 15.49
Pacira Pharmaceuticals (PCRX) United States $1.544B 56.20
Ironwood Pharmaceuticals (IRWD) United States $1.501B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.398B 23.06
Radius Health (RDUS) United States $1.331B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.266B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.066B 0.00
Aerie Pharmaceuticals (AERI) United States $1.052B 0.00
ArQule (ARQL) United States $0.964B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.942B 4.20
TherapeuticsMD (TXMD) United States $0.895B 0.00
Endo (ENDP) Ireland $0.761B 1.34
Karyopharm Therapeutics (KPTI) United States $0.701B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.677B 0.00
Concordia (CXRXF) Canada $0.673B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.567B 0.00
Flexion Therapeutics (FLXN) United States $0.561B 0.00
Organogenesis Holdings (ORGO) United States $0.553B 0.00
Lannett Co Inc (LCI) United States $0.542B 5.71
Akebia Therapeutics (AKBA) United States $0.537B 0.00
Translate Bio (TBIO) United States $0.515B 0.00
Aptorum Group (APM) China $0.486B 0.00
ImmunoGen (IMGN) United States $0.469B 0.00
Dova Pharmaceuticals (DOVA) United States $0.462B 0.00
Siga Technologies (SIGA) United States $0.460B 1.07
Indivior (INVVY) United States $0.459B 1.66
Innate Pharma SA (IPHYF) France $0.455B 0.00
ChemoCentryx (CCXI) United States $0.441B 0.00
Dermira (DERM) United States $0.438B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.429B 19.49
Crinetics Pharmaceuticals (CRNX) United States $0.405B 0.00
Collegium Pharmaceutical (COLL) United States $0.390B 0.00
DURECT (DRRX) United States $0.365B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.354B 0.00
Harpoon Therapeutics (HARP) United States $0.344B 0.00
OptiNose (OPTN) United States $0.322B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.320B 0.00
Ardelyx (ARDX) United States $0.306B 0.00
Rafael Holdings (RFL) United States $0.288B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.287B 0.00
Xeris Pharmaceuticals (XERS) United States $0.279B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.279B 0.00
CV Sciences (CVSI) United States $0.274B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.273B 0.00
Recro Pharma (REPH) United States $0.264B 0.00
Concert Pharmaceuticals (CNCE) United States $0.259B 0.00
KalVista Pharmaceuticals (KALV) United States $0.253B 0.00
Molecular Templates (MTEM) United States $0.232B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.218B 0.00
Calithera Biosciences (CALA) United States $0.207B 0.00
Ocular Therapeutix (OCUL) United States $0.202B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.200B 0.00
GlycoMimetics (GLYC) United States $0.196B 0.00
CannTrust Holdings (CTST) Canada $0.194B 0.00
Nature's Sunshine Products (NATR) United States $0.187B 31.29
Generex Biotechnology (GNBT) United States $0.170B 0.00
Redhill Biopharma (RDHL) Israel $0.168B 0.00
IMV INC (IMV) Canada $0.164B 0.00
Taiwan Liposome (TLC) Taiwan $0.160B 0.00
ElectroCore (ECOR) United States $0.147B 0.00
MEI Pharma (MEIP) United States $0.138B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.137B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.124B 0.00
Cardiome Pharma (CORV) Canada $0.119B 0.00
Jounce Therapeutics (JNCE) United States $0.112B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.112B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Majesco Entertainment (PTE) United States $0.105B 0.00
Mast Therapeutics (SVRA) United States $0.100B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.096B 0.00
Genocea Biosciences (GNCA) United States $0.091B 0.00
AgeX Therapeutics (AGE) United States $0.090B 0.00
Iterum Therapeutics (ITRM) Ireland $0.088B 0.00
Neos Therapeutics (NEOS) United States $0.086B 0.00
MediWound (MDWD) Israel $0.086B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.086B 0.00
RENEURON GP (RNUGF) United Kingdom $0.084B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.081B 31.12
Aquestive Therapeutics (AQST) United States $0.081B 0.00
Nivalis Therapeutics (ALPN) United States $0.077B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.076B 0.00
Natural Alternatives (NAII) United States $0.074B 7.44
Lipocine (LPCN) United States $0.072B 0.00
Novan (NOVN) United States $0.072B 0.00
Champions Oncology (CSBR) United States $0.071B 0.00
Otonomy (OTIC) United States $0.068B 0.00
Infinity Pharmaceuticals (INFI) United States $0.066B 0.00
Jaguar Animal Health (JAGX) United States $0.065B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.065B 0.00
SCYNEXIS (SCYX) United States $0.065B 0.00
China SXT Pharmaceuticals (SXTC) China $0.059B 0.00
Aclaris Therapeutics (ACRS) United States $0.058B 0.00
Capnia (SLNO) United States $0.055B 0.00
IntelGenx Technologies (IGXT) Canada $0.052B 0.00
CTI BioPharma (CTIC) United States $0.051B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.051B 0.00
Medicure (MCUJF) Canada $0.051B 0.00
Forward Pharma (FWP) Denmark $0.050B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.047B 1.61
India Globalization Capital (IGC) United States $0.046B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.045B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.045B 0.00
Melinta Therapeutics (MLNT) United States $0.041B 0.00
Mannatechorporated (MTEX) United States $0.039B 0.00
Opexa Therapeutics (ACER) United States $0.035B 0.00
Bio-Path Holdings (BPTH) United States $0.034B 0.00
PharmAthene (ALT) United States $0.031B 0.00
Biomerica (BMRA) United States $0.030B 0.00
IsoRay (ISR) United States $0.025B 0.00
Heat Biologics (HTBX) United States $0.021B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.020B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.018B 0.00
Regulus Therapeutics (RGLS) United States $0.017B 0.00
Achieve Life Sciences (ACHV) United States $0.017B 0.00
HANCOCK JAFFE (HJLI) United States $0.016B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.016B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Vical (BBI) United States $0.014B 0.00
Shineco (TYHT) China $0.013B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.011B 0.00
Onconova Therapeutics (ONTX) United States $0.010B 0.00
VAXART, INC (VXRT) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
RXi Pharmaceuticals (PHIO) United States $0.008B 0.00
Hemispherx BioPharma (AIM) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Flex Pharma (SLRX) United States $0.004B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00